Nuvectis Pharma, Inc. - Common Stock

Share · US67080T1088 · NVCT (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

04.11.2025 21:00

Current Prices from Nuvectis Pharma, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NVCT	USD	04.11.2025 21:00	5,88 USD	-0,48 USD -7,55 %

Share Float & Liquidity

Free Float 53,55 %

Shares Float 13,63 M

Shares Outstanding 25,46 M

Company Profile for Nuvectis Pharma, Inc. - Common Stock Share

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Get up to date insights from finAgent about Nuvectis Pharma, Inc. - Common Stock

Company Data

Name Nuvectis Pharma, Inc. - Common Stock

Company Nuvectis Pharma, Inc.

Symbol NVCT

Website https://www.nuvectis.com

Primary Exchange

NASDAQ

ISIN US67080T1088

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Ron Bentsur

Market Capitalization 162 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1 Bridge Plaza, 07024 Fort Lee

IPO Date 2022-02-04

Ticker Symbols

Name	Symbol
NASDAQ	NVCT

More Shares

Investors who hold Nuvectis Pharma, Inc. - Common Stock also have the following shares in their portfolio:

TOYOTA MOTOR CRD 2021 MTN Bond

USA 23/33 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog